dc.contributor.advisor | Sarafianos, Stefan G. | eng |
dc.contributor.author | Michailidis, Eleftherios | eng |
dc.date.issued | 2012 | eng |
dc.date.submitted | 2012 Summer | eng |
dc.description | Title from PDF of title page (University of Missouri--Columbia, viewed on July 31, 2013). | eng |
dc.description | The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. | eng |
dc.description | Dissertation advisor: Dr. Stefan G. Sarafianos | eng |
dc.description | Includes bibliographical references. | eng |
dc.description | Vita. | eng |
dc.description | Ph. D. University of Missouri-Columbia 2012. | eng |
dc.description | "July 2012" | eng |
dc.description.abstract | [ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Although human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) are very different viruses, the replication of their genome involves a reverse transcription process catalyzed by the viral reverse transcriptase (RT). Nucleoside reverse transcriptase inhibitors (NRTIs) are widely used for the treatment of HIV-1 and HBV infections. Unfortunately, the viruses manage to escape treatment by developing resistance. The main focus of this research is EFdA, a deoxyadenosine analog which blocks HIV-1 replication with remarkable potency. The inhibition stems mainly from the inability of the EFdA-terminated primer to translocate which is a novel mechanism therefore we termed EFdA as a translocation defective RT inhibitor (TDRTI). EFdA is shown here to be very effective not only against wild-type viruses but also against viruses that are resistant to widely used antiretrovirals. | eng |
dc.description.bibref | Includes bibliographical references. | eng |
dc.format.extent | xx, 193 pages | eng |
dc.identifier.oclc | 872569373 | eng |
dc.identifier.uri | https://hdl.handle.net/10355/36771 | |
dc.identifier.uri | https://doi.org/10.32469/10355/36771 | eng |
dc.language | English | eng |
dc.publisher | University of Missouri--Columbia | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. Graduate School. Theses and Dissertations | eng |
dc.rights | Access is limited to the campus of the University of Missouri--Columbia. | eng |
dc.subject | reverse transcriptase | eng |
dc.subject | deoxyadenosine analog | eng |
dc.subject | translocation defective RT inhibitor | eng |
dc.subject | antiretroviral | eng |
dc.title | Mechanisms of inhibition and resistance to antiviral drugs targeting human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) | eng |
dc.type | Thesis | eng |
thesis.degree.discipline | Microbiology (Medicine) (MU) | eng |
thesis.degree.grantor | University of Missouri--Columbia | eng |
thesis.degree.level | Doctoral | eng |
thesis.degree.name | Ph. D. | eng |